Abstract | CONTEXT: OBJECTIVE: PATIENTS AND METHODS: One hundred thirteen hypertensives without PA and 61 normotensive controls underwent an ultralow-dose (0.03-μg) ACTH stimulation and a treadmill test. Patients with ALD hyper-response according to the cutoffs obtained from controls received treatment with MRAs and underwent genomic DNA testing for the presence of the CYP11B1/ CYP11B2 chimeric gene and KCNJ5 gene mutations. A control group of 22 patients with simple ESHT received treatment with MRAs. RESULTS: Based on the cutoffs of ALD and aldosterone-to- renin ratio (ARR) post- ACTH stimulation obtained from controls, 30 patients (27%) exhibited an ALD but not cortisol (F) hyper-response (HYPER group). This group had no difference in basal ACTH/ renin (REN) concentrations compared with controls and the 83 patients with hypertension (73%) without an ALD hyper-response to ACTH stimulation. Patients in the HYPER group demonstrated significantly higher ALD concentrations, ARR, and ALD/ ACTH ratio (AAR) in the treadmill test. Treatment with MRAs alone produced normalization of blood pressure in these patients whereas patients with hypertension with neither PA nor ALD hyper-response to ACTH stimulation who served as a control group failed to lower blood pressure. Also, two novel germline heterozygous KCNJ5 mutations were detected in the HYPER group. CONCLUSIONS: A number of patients with hypertension without PA show ACTH-dependent ALD hyper-secretion and benefit from treatment with MRAs. This could be related to chronic stress via ACTH hyper secretion and/or gene-mutations increasing the zona glomerulosa responsiveness to excitatory stimuli.
|
Authors | Athina Markou, Amalia Sertedaki, Gregory Kaltsas, Ioannis I Androulakis, Chrisanthi Marakaki, Theodora Pappa, Aggeliki Gouli, Labrini Papanastasiou, Stelios Fountoulakis, Achilles Zacharoulis, Apostolos Karavidas, Despoina Ragkou, Evangelia Charmandari, George P Chrousos, George P Piaditis |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 100
Issue 8
Pg. 2857-64
(Aug 2015)
ISSN: 1945-7197 [Electronic] United States |
PMID | 25974737
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- G Protein-Coupled Inwardly-Rectifying Potassium Channels
- KCNJ5 protein, human
- Mutant Chimeric Proteins
- Aldosterone
- Adrenocorticotropic Hormone
- Cytochrome P-450 CYP11B2
- Steroid 11-beta-Hydroxylase
- Renin
- Hydrocortisone
|
Topics |
- Adenoma
(complications, genetics, metabolism)
- Adrenal Gland Neoplasms
(complications, genetics, metabolism)
- Adrenocorticotropic Hormone
(blood)
- Aldosterone
(blood, metabolism)
- Case-Control Studies
- Cytochrome P-450 CYP11B2
(genetics)
- Essential Hypertension
- G Protein-Coupled Inwardly-Rectifying Potassium Channels
(genetics)
- Humans
- Hydrocortisone
(blood)
- Hyperaldosteronism
(complications, genetics, metabolism)
- Hypertension
(complications, genetics, metabolism)
- Middle Aged
- Mutant Chimeric Proteins
(genetics)
- Renin
(blood)
- Steroid 11-beta-Hydroxylase
(genetics)
- Stress, Psychological
(genetics, metabolism)
|